Brevan Howard Capital Management LP Iovance Biotherapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $12.7 Billion
- Q1 2024
A detailed history of Brevan Howard Capital Management LP transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 233,330 shares of IOVA stock, worth $1.87 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
233,330
Previous 692,775
66.32%
Holding current value
$1.87 Million
Previous $5.63 Million
38.62%
% of portfolio
0.03%
Previous 0.09%
Shares
6 transactions
Others Institutions Holding IOVA
# of Institutions
303Shares Held
221MCall Options Held
3.05MPut Options Held
1.6M-
Vanguard Group Inc Valley Forge, PA24.9MShares$200 Million0.01% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$192 Million40.86% of portfolio
-
Black Rock Inc. New York, NY19.9MShares$160 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY19.3MShares$155 Million5.99% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.7MShares$93.8 Million2.09% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.27B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...